WAL Stock Forecast & Price Target

Western Alliance is supported by a deliberate deposit optimization strategy that reduced about $1.9B of higher-cost deposits in 2Q and early 3Q, with another $1B decline expected over the remainder of 3Q, improving funding quality even as 3Q deposit growth is still expected to be about $1B. The outlook remains constructive because, despite lower 2026 loan and deposit growth targets of $5B and $6B, net interest income growth guidance was still tightened upward to 12%-14% from 11%-14%, while CET1 is expected to remain around 11%, leaving room for about $150M of share repurchases over the remainder of 2026. The company also appears to be making tangible credit progress, with NPAs expected to trend lower in the 2H26 base case, a $99M life sciences/office CRE credit now current, and two of six CRE credits already resolved in July, while reported 2Q26 EPS of $2.36 and PPNR/share of $3.82 show underlying earnings power despite near-term pressure from higher noninterest expense, provisions, and softer fee income visibility.

Western Alliance is facing a weaker earnings and revenue trajectory as management cut 2026E / 2027E EPS to $8.49 / $11.40 from $9.10 / $11.55, reflecting lower PPNR and a reduced FY26 growth outlook, while non-FTENII is now guided to only 12-14% and fee growth ex. securities gains to 13-17% instead of 20-25%. Despite 12.0% linked-quarter loan growth to $60.9B, the balance sheet mix is deteriorating from a quality and funding perspective: period-end deposits fell $849M quarter over quarter as the bank deliberately reduced higher-cost balances by more than $1B late in 2Q and another $1B early in 3Q, while ECR-related costs rose 7% to $31.6B and higher expenses pressured NIE. Asset quality is also a concern, with NPAs up 12% from $615M to $688M, criticized loans still elevated at $1.3B, and higher NPA levels tied to a previously disclosed life sciences office CRE loan, leaving the stock exposed to further deterioration in credit quality, margin pressure, and a less profitable earning asset mix.